The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Compound Annual Growth ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics SHELTON, CT / ACCESS Newswire / May 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (t ...

The study demonstrates how generative deep learning, when combined with structural prediction and affinity modeling, can ...

NanoViricides, Inc. (NYSE American: NNVC) provided a strategic update on its antiviral pipeline, highlighting NV-387 as a potential breakthrough trea ...

PPIs like omeprazole (Prilosec) and esomeprazole (Nexium) are widely used to treat heartburn and acid reflux. Long-term use ...

The kissing disease affects 90% of adults and could explain your fatigue and brain fog. Discover how Epstein-Barr virus might ...

“This trial brings us closer to realizing ProLectin-M's potential as a first-line antiviral," said Dr. Leslie Ajayi, Bioxytran's Chief Medical Officer. "The consistency of our results, including 100% ...

Harvard University announced Wednesday that it will dedicate an initial $250 million toward backfilling some of the Trump ...

BIOXYTRAN, INC. (OTCQB: BIXT) (the "Company"), a clinical stage biotechnology company developing novel antiviral therapies, today announced the ...

The Vigilant research network is funded by the European Union. The E.U. established the network to take a proactive approach ...

New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding ...